For widespread eczema covering large body surface areas, systemic delivery (subcutaneous injection) ensures all affected areas receive benefit without the impracticality of applying topical preparations everywhere
1 Four abstracts in total were presented, highlighting a breadth of results with oral semaglutide 25 mg during ObesityWeek 2025 in Atlanta, GA
In addition, it is difficult to apply the results of this study to humans because it is not common to administer GLP-1RA under fasting conditions in humans
It may offer a more balanced approach for those dealing with metabolic or hormone-related weight gain
Soluble fiber, in particular, slows digestion and increases GLP release in the gut
Douros A, Lix LM, Fralick M, DellAniello S, Shah BR, Ronksley PE, et al